2,4-Dichloro-3-(trifluoromethyl)pyridine, 97.0%, 5g

5-Amino-N-(4-chlorophenyl)-2-methoxybenzene-1-sulfonamide, 97%, 250mg

Accessories protective caps, Protective cap type H 103 for RH digital, 1 piece

2,6-Dichloro-1,7-naphthyridine, 95.0%, 1g

{[4-(benzyloxy)phenyl]methyl}(prop-2-en-1-yl)amine, 95.0%, 10g

1-Phenyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-benzo[d]imidazole, 95.0%, 5g

3-Bromo-1,7-naphthyridin-8(7H)-one, 97.0%, 250mg

2-((4,4-Dimethyl-1-oxidothiochroman-6-yl)ethynyl)pyrimidine-5-carboxylic acid, 98+%, 5mg

EXO-6-AMINO-3-BOC-3-AZABICYCLO[3.1.0]HEXANE, 95.0%, 1g

(2R,3S,4S,5S,6R)-2-(Hydroxymethyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol, 98%, 250mg

3-BROMO-5-FLUORO-2-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95.0%, 250mg

4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-N-(3-(trifluoromethyl)phenyl)benzamide, 98%, 250mg

6-Amino-1,4-dihydro-quinoxaline-2,3-dione, 98.0%, 250mg